Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab

NCT03974425 is registered in ClinicalTrials.gov with University of Alexandria as lead sponsor.

NCT NCT03974425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03974425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab
Lead sponsor
University of Alexandria
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2016
Completion date
April 1, 2018
Enrollment
37 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema